Abate AS Industries
add_icon

Abate AS Industries

11.18
+0.27
(2.47%)
Market Cap
176.15 Cr
PE Ratio
16.28
Volume
1,261.00
Day High - Low
11.20 - 10.32
52W High-Low
50.53 - 10.01
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
176.15 Cr
EPS
0.59
PE Ratio
16.28
PB Ratio
1.01
Book Value
10.77
EBITDA
1.70
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
0.60
Debt to Equity
0.06
Forecast For
Actual

Company News

View All News
Caret
neutral
NPMED Healthcare LLP disposed of 2,26,03,900 shares representing 14.34% of Abate As Industries Limited through open market transactions on April 20, 2026. Post-disposal, the seller's holding reduced to 10.09% with 1,59,06,020 shares.
neutral
Abate AS Industries Limited submitted newspaper advertisement to BSE confirming completion of postal ballot notice dispatch on April 9, 2026 for Independent Director regularization.
neutral
ABATE AS Industries Limited notifies BSE that it does not qualify as a Large Corporate under SEBI regulations as of March 31, 2026, exempting it from specific debt securities compliance requirements.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,756.00
#1 1,11,519.38
59.89
#1 21,994.30
14.76
#1 1,505
36.08
60.48
1,007.85
98,077.42
69.07
7,184.10
#1 28.68
1,076
26.01
56.00
922.30
69,629.79
71.34
7,849.70
13.25
809
-22.38
68.77
1,790.30
36,586.71
47.12
5,575.00
12.29
790
-34.33
58.16
695.90
36,056.04
99.25
4,286.70
15.12
337
-8.85
57.74
1,105.30
29,709.40
58.06
3,771.40
12.59
481
-33.52
61.55
648.80
25,961.01
83.13
3,067.00
21.98
415
-43.89
47.12
447.00
14,161.30
90.87
1,757.00
27.64
110
#1 54.61
64.60
1,249.70
12,691.85
49.60
1,566.90
17.46
244
7.26
59.65
233.10
10,068.31
#1 36.59
1,426.00
12.90
213
15.54
68.10
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
13.41 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
0
0
0
15
42
43
43
Expenses
0
0
0
13
39
38
39
EBITDA
0
0
0
2
3
5
4
Operating Profit %
0 %
0 %
0 %
6 %
6 %
9 %
9 %
Depreciation
0
0
0
1
1
1
1
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
1
2
4
3
Tax
0
0
0
0
0
0
0
Net Profit
0
0
0
1
2
4
3
EPS in ₹
-0.07
-0.05
-0.05
0.30
0.10
0.19
0.13

Balance Sheet

Balance Sheet
2025
Total Assets
206
Fixed Assets
149
Current Assets
42
Capital Work in Progress
0
Investments
14
Other Assets
43
Total Equity & Liabilities
206
Current Liabilities
16
Non Current Liabilities
4
Total Equity
186
Reserve & Surplus
85
Share Capital
79

Cash Flow

Cash Flow
2025
Net Cash Flow
2
Investing Activities
-162
Operating Activities
-1
Financing Activities
165

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
May 2025
Jun 2025
Aug 2025
Sept 2025
Dec 2025
Promoter
20.88 %
20.88 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
31.87 %
27.56 %
27.56 %
27.56 %
27.56 %
27.56 %
27.56 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
69.28 %
61.66 %
63.22 %
63.19 %
63.60 %
63.56 %
63.41 %
61.02 %
60.31 %
59.95 %
59.92 %
59.37 %
58.62 %
58.04 %
58.24 %
58.46 %
47.38 %
47.31 %
47.42 %
47.45 %
47.50 %
3.83 %
Others
9.84 %
17.46 %
4.92 %
4.95 %
4.53 %
4.58 %
4.72 %
7.12 %
7.83 %
8.19 %
8.21 %
8.76 %
9.51 %
10.10 %
9.90 %
9.68 %
25.05 %
25.12 %
25.02 %
24.99 %
24.94 %
68.60 %
No of Share Holders
1,237
1,265
1,238
1,224
1,170
1,145
1,131
1,115
1,109
1,091
1,069
1,050
1,028
1,010
1,046
1,050
1,067
1,057
1,050
2,272
2,435
2,580

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
22 Oct 2021 CHANGE OF NAME Change Of Name
NA
22 Oct 2021 0.00 0.00
11 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Sept 2024 25.05 22.30
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 18.08 17.18
05 Feb 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
05 Feb 2025 17.46 17.46
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 17.46 18.33
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 20.20 20.20
14 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
14 Jul 2025 21.21 39.15
31 Jul 2025 BONUS Bonus
1:1
31 Jul 2025 48.57 49.44
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 24.37 22.96
10 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Nov 2025 16.87 16.88
12 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2026 10.74 12.54

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 08, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 08, 2026
Circular Resolution Passed By Board Of Directors On 8Th April 2026Apr 08, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 06, 2026
Closure of Trading WindowMar 26, 2026
Disclosure Under Regulation 29(2) Of The SEBI( Substantial Acquisition Of Shares And Takeovers) Regulations 2011Mar 25, 2026
Intimation Under Regulation 7(2) Of The SEBI (PIT) Regulations 2015 As Received From ASYAMar 25, 2026
Introduction Of KeralaS First Alcon Vision Suite (AVS) BY Abate Eye HospitalMar 24, 2026
Intimation Under Regulation 7(2) Of The SEBI (PIT) Regulations 2015 As Received From Al Salama Eye Research FoundationMar 10, 2026
Intimation Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 02, 2026
Announcement Under Regulation 30- Launch Of AbateS Indigenous EMR & Integrated Eye Hospital Clinic Management SystemFeb 17, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 12, 2026
Unaudited Standalone And Consolidated Financial Results For Quarter Ended 31.12.2025Feb 12, 2026
Board Meeting Outcome for Submission Of Outcome Of Board Meeting Held On 12Th February 2026Feb 12, 2026
Board Meeting Intimation for Approving Unaudited Financial Results For The Quarter Ended 31St December 2025Feb 06, 2026
Regulation 30 - Clarification On Significant Movement In The Price Of Companys SecurityFeb 05, 2026
Clarification sought from Abate As Industries LtdFeb 04, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 05, 2026
Closure of Trading WindowDec 27, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateNov 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 27, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 20, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Empanelment Of Abate Eye Hospitals (A Business Division Of Prudential Management Services Ltd A Subsidiary Of Abate Industries Ltd) Under NORKA Care Policy For Cashless Health ServicesNov 11, 2025
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 10, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th November 2025Nov 10, 2025
Board Meeting Intimation for To Be Held On 10Th November 2025Nov 04, 2025
Introduction Of Advanced Refraction Technology ZEISS VISUCORE 500.Nov 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 27, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 16, 2025
Board Meeting Outcome for For Meeting Held On 15Th October 2025Oct 15, 2025
Board Meeting Intimation for Meeting To Be Held On 15Th October 2025Oct 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 06, 2025
Closure of Trading WindowSep 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Submission Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2025Aug 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2025Aug 13, 2025
Board Meeting Intimation for Approving Unaudited Financial Results For The Quarter Ended 30 June 2025Aug 08, 2025
Announcement under Regulation 30 (LODR)-AllotmentAug 01, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 01 2025Aug 01, 2025
The Company Has Fixed Thursday July 31 2025 As The Record Date For The Purpose Of Ascertaining The Eligibility Of Shareholders Entitled For Issuance Of Fully Paid-Up Bonus Equity Shares.Jul 23, 2025
Reg. 34 (1) Annual Report.Jul 22, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 15, 2025

Technical Indicators

RSI(14)
Neutral
41.07
ATR(14)
Volatile
0.89
STOCH(9,6)
Neutral
34.49
STOCH RSI(14)
Oversold
6.92
MACD(12,26)
Bearish
-0.01
ADX(14)
Weak Trend
13.89
UO(9)
Bearish
51.54
ROC(12)
Downtrend And Accelerating
-4.47
WillR(14)
Neutral
-76.39